Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Vemurafenib

EU orphan designation number: EU/3/17/1846   
Active ingredient: Vemurafenib
Indication: Treatment of Erdheim-Chester disease
Sponsor: Groupe d'étude des histiocytoses
Hôpital Trousseau, 26 avenue du Dr Netter, Paris 75012, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/03/2017 Orphan designation EMA/OD/281/16 (2017)1512 of 27/02/2017